IntroductionOften dismissed as a cosmetic concern, vitiligo is anything but given its pathophysiology and tremendous impact on quality of life (QoL). Simply put- vitiligo is a medical disease,1 exhibiting an…
Read More
INTRODUCTIONAs with much of dermatology, most research on wound healing has been based on afflictions in light skin, resulting in a dearth of evidence-based protocols on the management of wound…
Read More
INTRODUCTIONThe Burden of Melasma Melasma is a clinically diagnosed benign acquired pigmentary disorder that typically presents as symmetric, reticulated hypermelanosis with irregular borders. It appears on the centrofacial region (ie,…
Read More
INTRODUCTIONDiabetes mellitus (DM) type 1 (DM-1) and type 2 (DM-2) is a worldwide public health problem affecting over 460 million people globally in 2019; and estimated to rise to 578…
Read More
IntroductionThe immune response comprises a complex cascade of reactions that balances effector and regulatory functions.1 While the effector’s arm includes cellular and molecular components responsible for preventing cellular infections and…
Read More
INTRODUCTIONHzailey-Hailey disease (HHD), or benign familial pemphigus, is an uncommon blistering disorder that presents as recurrent vesicles and erosions. These lesions often appear in the third to fourth decade of…
Read More
INTRODUCTIONLocal anesthesia is used in over one-million cutaneous surgeries per year, allowing providers to successfully perform many outpatient and office-setting surgeries.1 However, administration of local anesthesia has drawbacks, including the…
Read More
INTRODUCTIONPrivate equity-backed dermatology groups (PEGs) have been a subject of much interest among the dermatology community throughout the country. Recent trends indicate a growing number of physician-owned dermatology practices being…
Read More
INTRODUCTIONRecurrent aphthous stomatitis (RAS) is the most common oral lesion; it has unknown etiology and is characterized by periodic oval, shallow, painful ulcers, gray or yellowish in color, which are…
Read More
INTRODUCTIONAn estimated 15-25% of the population has previously experienced urticaria, with the highest prevalence in women and the middle-aged population.1 Chronic urticaria (CU) is defined as wheals, angioedema, or both,…
Read More
INTRODUCTIONPsoriasis is a chronic immune-mediated inflammatory disease affecting the skin. First-line treatment for mild-to-moderate psoriasis is topical treatment, including corticosteroids, vitamin D analogs, keratinolytics, calcineurin inhibitors, salicylic acid, and tar.1,2…
Read More
INTRODUCTIONBrodalumab is an interleukin-17 receptor A antagonist indicated for the systemic treatment of moderate-to-severe plaque psoriasis in adult patients who have lost response or failed to respond to other systemic…
Read More
